Published: 2017-06-24

Percutaneous transcatheter intervention in a cyanotic congenital heart disease at tertiary care hospital in Western Rajasthan: a single centre experience

Rohit Mathur, Deepak Gupta, Goutam Kumar, Sanjeev Sanghvi, Anil Baroopal


Background: Treatment of congenital heart disease (CHD) is either surgical or interventional. Medical management is mainly symptomatic or palliative. Although surgery is the main mode of treatment but in the recent past non-surgical interventional method is replacing it because of its multiple advantages over surgical procedures. In this article, we report the success rate of the percutaneous transcatheter device closure procedures in our tertiary care hospital.

Methods: The aim of this study is to review the short-term outcome of the non-surgical interventional treatment of congenital heart diseases. We included percutaneous transcatheter device closure of atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus (PDA) and ruptured sinus of valsalva aneurysm (SVA) performed at our hospital between September 2014 and November 2016.

Results: We performed total 28 cases of ASD device, 3 cases of VSD device, 12 cases of PDA device, 2 cases of ruptured SVA device closures. Almost all our intervention procedures were successful except two cases of failure of ASD closure. There was no mortality and major complication related to procedures. All patients of successful interventional treatment are enjoying new life without any morbidity.

Conclusions: Percutaneous transcatheter device closure for suitably selected cases of a cyanotic CHDs including ASD, VSD, PDA and ruptured SVA may be an alternative, lucrative, safe and effective option with least morbidity and mortality.


CHD, Percutaneous transcatheter intervention

Full Text:



Dugal JS, Jetley V, Singh C, Datta SK, Sabharwal JS, Sofat S. Amplatzer Device closure of atrial septal defect and patent ductus arteriosus: initial experience. MJAFI. 2003;59:218-22.

Welsby IJ, Bennett GE, Atwell D, White WD, Newman MF, Smith PK, et al. The association of complication type with mortality and prolonged stay after cardiac surgery with cardiopulmonary bypass. Anesth Analg. 2002:1072-8.

Kazmi T, Sadiq M, Asif-ur-Rehman, Hyder N, Latif F. Intermediate and long-term outcome of patients after device closure of ASD with specific reference to complication. J Ayub Med Coll Abbottabad. 2009;21:117-21.

Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of great arteries. JAMA. 1966;196(11):991-2.

Porstmann W, Wierny L, Warneke H. Closure of persistent ductus arteriosus without thoracotomy. Ger Med. 1967;12:259-61.

Barry Love. Non-Surgical alternative to repair congenital heart defects. US Cardiol. 2005;2:1-6.

Gross RE, Hubbard JP. Surgical ligation of a patent ductus arteriosus: report of the first successful case. JAMA 1939;112:729.

Masura J, Walsh KP, Thanopoulous B, Chan C, Bass J, Goussou Y, et al. Catheter closure of moderate to large sized patent ductus arteriosus using the new amplatzer duct occluder. Immediate and short-term results. J Am Coll Cardiol. 1998;31:878-2.

Shah RP, Ding ZP, Ng AS, Quek SS. A Ten-Year review of ruptured sinus of Valsalva: clinico-pathological and echo-Doppler features. Singapore Med J. 2001;42:473-6.

Perloff JK. Congenital aneurysms of the sinuses of Valsalva. In: Perloff JK, ed. Clinical Recognition of Congenital Heart Disease. 6th ed. Philadelphia: Saunders WB; 2012:417-428.

Lillehei CW, Stanley P, Varco RL. Surgical treatment of ruptured aneurysms of the sinus of Valsalva. Ann Surg. 1957;146:459-72.

Trehan VK, Mukhopadhyay S, UmaMahesh CR, Yusuf J, Arora R. Successful transcatheter closure of ruptured sinus of Valsalva Aneurysm. Indian Heart J. 2002;54:720-2.

Rashkind WJ, Causo CC. Transcatheter closure of patent ductus arteriosus: successful use in a 3.5 kg infant. Pediatr Cardiol. 1979;1:3-7.

Cambier PA, Kirby WC, Worthham DC, Moore JW. Percutaneous closure of the small (<2.5 mm) patent ductus arteriosus using coil embolization. Am J Cardiol. 1992;69:815-6.

Pass RH, Hijazi Z, Hsu DT, Lewis V, Hallenbrand WE. Multicentre USA study, amplatzer patent ductus arteriosus occlusion device trial: initial and one year results. J Am Coll Cardiol. 2004;44:513-9.

King TP, Mills NL. Non-operative closure of Atrial Septal Defect. Surg. 1974;75:383-8.

Du ZD, Hijazi ZM, Klienmann CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicentre nonrandomized trial. J Am Coll Cardiol. 2002;39:1836-44.

Abaci A, Unlu S, Alsancak Y, Kaya Y, Sezenoz B. Short and long-term complications of device closure of atrial septal defects and foramen ovale: meta-analysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv. 2013;82(7):1123-38.

Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk. Catheter Cardivasc Interv. 2004;63:496-502.

Lock JE, Block PC, Mckay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988;78:361-8.

Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee KJ. Complete heart block associated with device closure of peri membranous ventricular septal defects. J Thorac Cardiovasc Surg. 2008;136:1223-8.

Koneti NR, Sreeram N, Penumatsa RR, Arramraj SK, Karunakar V, Trieschmann U. Transcatheter retrograde closure of ventricular septal defects in children with the amplatzer duct occluder 2 device. J Am Coll Cardiol. 2012;60:2421-2 .

Cullen S, Somerville J, Redington A. Transcather closure of a ruptured aneurysm of the sinus of Valsalva. Br Heart J. 1994;71:479-80.

Chang CW, Chiu SN, Wu ET, Tsai SK, Wu MH, Wang JK. Transcatheter closure of a ruptured sinus of Valsalva aneurysm. Circ J. 2006;70:1043-7.